ROLE OF ENDOGENOUS AND EXOGENOUS LIGANDS FOR THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α IN THE DEVELOPMENT OF BLEOMYCIN-INDUCED LUNG INJURY
- 1 December 2005
- journal article
- basic science-aspects
- Published by Wolters Kluwer Health in Shock
- Vol. 24 (6) , 547-555
- https://doi.org/10.1097/01.shk.0000190825.28783.a4
Abstract
The peroxisome proliferator-activated receptor-α (PPAR-α) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors related to retinoid, steroid, and thyroid hormone receptors. The aim of the present study was to examine the effects of endogenous and exogenous the PPAR-α ligand on the development of lung injury caused by bleomycin administration. Lung injury was induced in PPAR-α wild-type (WT) mice and PPAR-α knockout (KO) mice by intratracheal administration of bleomycin. An increase of immunoreactivity to poly-ADP-ribose, TNF-α, and IL-1β, as well as a significant loss of body weight and mortality was observed in the lung of bleomycin-treated PPAR-α WT mice. The absence of a functional PPAR-α gene in PPAR-α KO mice resulted in a significant augmentation of all the above-described parameters. On the contrary, the treatment of PPAR-α WT with WY-14643 (1 mg/kg daily) significantly reduced the degree of lung injury, the rise in myeloperoxidase activity, and the increase in staining (immunohistochemistry) for poly-ADP-ribose, TNF-α, and IL-1β caused by bleomycin administration. Thus, endogenous and exogenous PPAR-α ligands reduce the degree of lung injury induced by bleomycin in the mice. Therefore, we propose that the PPAR-α ligand may be useful in the treatment of lung injury.Keywords
This publication has 43 references indexed in Scilit:
- Protection from Pulmonary Fibrosis in Leukotriene-Deficient MiceAmerican Journal of Respiratory and Critical Care Medicine, 2002
- 5-Aminoisoquinolinone, a potent inhibitor of poly (adenosine 5′-diphosphate ribose) polymerase, reduces myocardial infarct sizeEuropean Journal of Pharmacology, 2001
- PG490-88, a Derivative of Triptolide, Blocks Bleomycin-Induced Lung FibrosisThe American Journal of Pathology, 2001
- PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancerTrends in Pharmacological Sciences, 2000
- Idiopathic Pulmonary Fibrosis: Diagnosis and TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Colchicine Versus Prednisone as Treatment of Usual Interstitial PneumoniaMayo Clinic Proceedings, 1997
- Corticosteroids and the Treatment of Idiopathic Pulmonary FibrosisChest, 1996
- Azathioprine Combined with Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Prospective Double-blind, Randomized, Placebo-controlled Clinical TrialAmerican Review of Respiratory Disease, 1991
- Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.Thorax, 1989
- The Steroid and Thyroid Hormone Receptor SuperfamilyScience, 1988